Session A: Product & Process
• PQLI
• Assessing Changes During Development of New Biologic Products
• QbD Submissions in Major Markets – Regulators Perspectives
• GMP Inspections
• Continuous Process Verification 
• Technology Transfer
• IR Tablet Process Development Using Science of Scale Tools

Session B: Manufacture & Quality Management
• The First Case of Drug Tech Transfer in china
• Sustainable GMP Implementation – Proactive Approach
• Aseptic Process Validation
• New Chinese GMP
• Quality system - elements of a CAPA System
• Process capability and continual process improvement
• Coping with inspections from a inspector's perspective
• QRM(Q9)
• Outsourcing quality management in China
• Key considerations when ensuring cold chain robustness

Session C: Facility design, refurbishment and operational management
• Risk management in facility design
• Major changes in newly published ISPE baseline & good practice
• Key Success Factors to Build cGMP-compliance Facility in China
• Risk Analysis and Control in Aseptic Process Engineering
• Commissioning & Qualification Services Integrated into the Pharmaceutical Project Lifecycle
• Facility commissioning, qualification and validation
• Major Design Aspects for a Bio Active Fill and Finish Facility
• Validation of Facility Management system
• Designing and Building your First Global Launch Biopharmaceutical Plant with Confidence

Registed Companies' name